MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

This study is testing MUC1-activated T cells — immune cells from your own blood that have been trained in a lab to recognize and attack a protein called MUC1 that is commonly found on ovarian cancer cells — in women with relapsed or treatment-resistant ovarian, fallopian tube, or primary peritoneal cancer. **You may be eligible if...** - You are 18 or older - You have been diagnosed with epithelial ovarian, fallopian tube, carcinosarcoma, or primary peritoneal cancer - Your cancer has come back or stopped responding to treatment, including at least one prior platinum-based chemotherapy - You have measurable disease on scans - You are otherwise well enough to participate **You may NOT be eligible if...** - You have active brain metastases - You have severe autoimmune disease or immune deficiency - You are pregnant or breastfeeding - You have had prior cell therapy or gene therapy Talk to your doctor to see if this trial is right for you.